235 related articles for article (PubMed ID: 21296323)
1. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
2. Deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Mitchell SL; Brock DW
Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
[TBL] [Abstract][Full Text] [Related]
3. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
Kramer DB; Kesselheim AS; Brock DW; Maisel WH
Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
[TBL] [Abstract][Full Text] [Related]
4. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
5. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Ottenberg AL; Gerhardson S; Mueller LA; Kaufman SR; Koenig BA; Mueller PS
J Interv Card Electrophysiol; 2011 Dec; 32(3):243-52. PubMed ID: 21805140
[TBL] [Abstract][Full Text] [Related]
6. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
7. [Dying with/despite a pacemaker].
Reith S; Janssens U
Med Klin Intensivmed Notfmed; 2014 Feb; 109(1):19-26. PubMed ID: 24384727
[TBL] [Abstract][Full Text] [Related]
8. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular implanted electronic devices in people towards the end of life, during cardiopulmonary resuscitation and after death: guidance from the Resuscitation Council (UK), British Cardiovascular Society and National Council for Palliative Care.
Pitcher D; Soar J; Hogg K; Linker N; Chapman S; Beattie JM; Jones S; George R; McComb J; Glancy J; Patterson G; Turner S; Hampshire S; Lockey A; Baker T; Mitchell S;
Heart; 2016 Jun; 102 Suppl 7():A1-A17. PubMed ID: 27277710
[TBL] [Abstract][Full Text] [Related]
10. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
England R; England T; Coggon J
J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
[TBL] [Abstract][Full Text] [Related]
11. Ethical challenges of deactivation of cardiac devices in advanced heart failure.
Chamsi-Pasha H; Chamsi-Pasha MA; Albar MA
Curr Heart Fail Rep; 2014 Jun; 11(2):119-25. PubMed ID: 24619521
[TBL] [Abstract][Full Text] [Related]
12. Ethical considerations for turning off pacemakers and defibrillators.
Karches KE; Sulmasy DP
Card Electrophysiol Clin; 2015 Sep; 7(3):547-55. PubMed ID: 26304534
[TBL] [Abstract][Full Text] [Related]
13. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
Wright GA; Klein GJ; Gula LJ
Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
[TBL] [Abstract][Full Text] [Related]
14. The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.
Carlsson J; Paul NW; Dann M; Neuzner J; Pfeiffer D
Dtsch Arztebl Int; 2012 Aug; 109(33-34):535-41. PubMed ID: 23152737
[TBL] [Abstract][Full Text] [Related]
15. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
16. Pacemaker deactivation: withdrawal of support or active ending of life?
Huddle TS; Amos Bailey F
Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
[TBL] [Abstract][Full Text] [Related]
17. Deactivation of cardiovascular implantable electronic devices in patients nearing end of life : Reality or only recommendation?
Tischer T; Bebersdorf A; Albrecht C; Manhart J; Büttner A; Öner A; Safak E; Ince H; Ortak J; Caglayan E
Herz; 2020 Dec; 45(Suppl 1):123-129. PubMed ID: 31312871
[TBL] [Abstract][Full Text] [Related]
18. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
Morgenweck CJ
Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
